Doi, T., Matsubara, N., Kawai, A., Naka, N., Takahashi, S., Uemura, H., & Yamamoto, N. (2019). Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors. Invest New Drugs.

Doi, Toshihiko, Nobuaki Matsubara, Akira Kawai, Norifumi Naka, Shunji Takahashi, Hiroji Uemura, och Noboru Yamamoto. "Phase I Study of TAS-115, a Novel Oral Multi-kinase Inhibitor, in Patients With Advanced Solid Tumors." Invest New Drugs 2019.

Doi, Toshihiko, et al. "Phase I Study of TAS-115, a Novel Oral Multi-kinase Inhibitor, in Patients With Advanced Solid Tumors." Invest New Drugs 2019.